Innovative Therapeutic Strategies in TYK2-Targeted Treatments: From Cancer to Autoimmune Disorders

被引：0
|
作者：
Kargbo, Robert B. [1 ]
机构：
[1] Usona Inst, Fitchburg, WI 53711 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2024年 / 15卷 / 02期
关键词：
D O I：
10.1021/acsmedchemlett.4c00004
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Recent advancements in therapeutic approaches targeting tyrosine kinase 2 (TYK2) have shown promising results across various medical fields, including oncology and immunology. TYK2, a Janus kinase (JAK) family member, plays a significant role in cytokine signaling and immune regulation. This Patent Highlight explores the latest developments in TYK2 inhibitors, highlighting their potential in treating diverse conditions such as cancer, alopecia areata, and psoriatic arthritis.
引用
收藏
页码：174 / 176
页数：3
相关论文
共 50 条
  • [1] TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseases
    Gonciarz, Maciej
    Pawlak-Bus, Katarzyna
    Leszczynski, Piotr
    Owczarek, Witold
    [J]. IMMUNOTHERAPY, 2021, 13 (13) : 1135 - 1150
  • [2] Targeted Therapeutic Strategies for the Treatment of Cancer
    Victoir, Benjamin
    Croix, Cecile
    Gouilleux, Fabrice
    Prie, Gildas
    [J]. CANCERS, 2024, 16 (02)
  • [3] Therapeutic Strategies for Neurological Disorders: From Natural Compounds to Innovative Molecular Designs
    Camins, Antoni
    Ettcheto, Miren
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (14) : I - II
  • [4] Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies
    Ferlito, Arianna
    Campochiaro, Corrado
    Tomelleri, Alessandro
    Dagna, Lorenzo
    De Luca, Giacomo
    [J]. JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2022, 7 (03) : 179 - 188
  • [5] Astrocyte-Targeted Therapeutic Strategies for Neurological Disorders
    Miyazaki, Ikuko
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (33) : 4933 - 4935
  • [6] RAIDs: Future prospects for innovative targeted treatments in cervical cancer
    Kamal, Maud
    Berns, Els
    Rondof, Windy Luscap
    De Koning, Leanne
    Kenter, Gemma
    Kerezst, Attila
    Popovic, Marina
    Kamoun, Choumouss
    Balint, Balazs
    Scholl, Suzy
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [7] The Promising Evolution of Targeted Therapeutic Strategies in Cancer
    Peters, Solange
    Mok, Tony
    Passaro, Antonio
    Janne, Pasi Antero
    [J]. CANCER DISCOVERY, 2021, 11 (04) : 810 - 814
  • [8] Therapeutic Advantage of Tyk2 Inhibition for Treating Autoimmune and Chronic Inflammatory Diseases
    Muromoto, Ryuta
    Shimoda, Kazuya
    Oritani, Kenji
    Matsuda, Tadashi
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (11) : 1585 - 1592
  • [9] Novel strategies and promising opportunities for targeted protein degradation: An innovative therapeutic approach to overcome cancer resistance
    Zhu, Huanjie
    Wang, Jin
    Zhang, Qingqing
    Pan, Xiaoyan
    Zhang, Jie
    [J]. PHARMACOLOGY & THERAPEUTICS, 2023, 244
  • [10] Epigenetic perturbations and cancer: innovative therapeutic strategies against cancer
    Reynoird, N.
    Rousseaux, S.
    Khochbin, S.
    [J]. BULLETIN DU CANCER, 2010, 97 (11) : 1265 - 1274
12345